Drug Product registration process in the US MasterClass
16-19 September, 2024
What the FDA is and how the entity is organized
The process of registering a pharmaceutical product for marketing in the USA involves several steps and several critical points to focus on.
16-19 September, 2024, Virtual
Starting time EDT 10:00 a.m. | PDT 07:00 a.m. | UTC 14:00 p.m. | CEST 16:00 p.m.
Overview
The process of registering a pharmaceutical product for marketing in the USA involves several steps and several critical points to focus on. The flow that the process must follow depends on the type of registration requested, as established by the FDA (Food and Drug Administration), responsible body for the oversight of quality and safety of all foods and medicines distributed in the USA. The purpose of this Master Class is to clarify the registration processes prescribed by the FDA, so to understand what information, documents, evidence must be available and how these should be presented or explained to the authorities. The course will be structured through a logical sequence of steps:
Initial understanding of what the FDA is and how the entity is organized
Understand the classification process applicable to a presentation and the relevant evaluation process
Management of special cases and understanding of any shortened processes
The second part of the Master Class will focus on the Audit, i.e. the direct verification by the FDA of the companys information and working methods, presenting the different inspection types. We will discuss how to define a correct readiness plan and which fundamental steps must be included, starting from the assessment of the current state up to the resolution of all identified gaps, the definition of the audit logistics, the organization of dedicated spaces, the assignment of responsibilities to team members, the right behaviors to observe during the audit period, how to establish good interaction with the Inspectors. The final section will focus on the conclusion of the Audit and what to expect in terms of possible outcomes, how to work at the preparation of the answer to the observations to respond comprehensively within the time allowed with the good satisfaction of the Agency request and the Company needing.
#masterclass #glceurope #pharmaonlinemasterclass #globalleadingconferences #drugproductregistration #FDAstructures
RECOMMENDATION
Who should attend?
Quality Control
Quality Assurance
Manufacturing
Engineering
IT
CSV
Regulatory Affairs
TR&D
Testimonial
Our success stories
"High attention to detail in course content and very well delivered"
Simon Halsey
Product Development Manager
Essentra Packaging
United Kingdom
Our success stories
"Very good training led by two knowledgeable and open experts. Excellent insight given on many complex topics. Interactive and highly useful"
Aurelie Vivicorsi
USP PD Team Manager
Celonic AG
Switzerland
Our success stories
"Great course, impressed with the knowledge of the trainers and ability to answer wide variety of questions!"
Emilia Szwej
Manager, Senior Investigator
MT Sword Laboratories (BMS)
Germany
About GLC
Global Leadership Conferences began as an ambitious dream by three founders ten years ago. Today its an international series of interactive events, exploring the hottest topics in critical fields. Each year, thousands of professionals join us to challenge the status quo and learn innovative ways to create new solutions in Finance, Pharmaceutical, HR, Health & Safety, and Energy.
know more >13+
Years of experience
500+
Events organized
3,970
Speakers
23,714
Attendees
Other events you may like
Drug Product registration process in the US MasterClass
16-19 September, 2024
What the FDA is and how the entity is organized
learn more >>Risk Based Monitoring MasterClass - EU edition
17-18 September, 2024
Learn how to define, evaluate, and respond to risks, and also how to define critical data.
learn more >>Risk Based Monitoring MasterClass - US edition
17-18 September, 2024
Learn how to define, evaluate, and respond to risks, and also how to define critical data.
learn more >>